Takeda Pharmaceutical Co (BSP:TAKP34) Buildings And Improvements : R$0 Mil (As of Mar. 2025)

View and export this data going back to 2019. Start your Free Trial

What is Takeda Pharmaceutical Co Buildings And Improvements?

Takeda Pharmaceutical Co's annual buildings and improvements increased from Mar. 2023 (R$54,559 Mil) to Mar. 2024 (R$55,810 Mil) but then declined from Mar. 2024 (R$55,810 Mil) to Mar. 2025 (R$0 Mil).

Takeda Pharmaceutical Co Buildings And Improvements Historical Data

The historical data trend for Takeda Pharmaceutical Co's Buildings And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Takeda Pharmaceutical Co Buildings And Improvements Chart

Takeda Pharmaceutical Co Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Buildings And Improvements

Get a 7-Day Free Trial

58,757.21

54,078.43

54,559.09

55,809.85

Takeda Pharmaceutical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Buildings And Improvements	Get a 7-Day Free Trial															55,809.85	-	-	-	-

Takeda Pharmaceutical Co Buildings And Improvements Calculation

Buildings are typically valued at the time of acquisition or construction. Broker and architect fees, permits, etc. can be covered within this category. Building components, such as a roof, are normally recorded separately in an asset register since the value and useful lives of these components equal much less than the building itself.

Building improvements that extend the useful life of a building will fall into the category of “building improvements” and should be capitalized. Improvements are commonly recorded at acquisition cost. Building improvement examples include roofing, remodeling, replacements, etc.

Takeda Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Takeda Pharmaceutical Co Ltd (BSP:TAKP34) » Definitions » Buildings And Improvements

Comparable Companies

Traded in Other Exchanges

TAK:USA TKPHF:USA 4502:Japan 4502:Japan 4502:Japan 0A87:UK TKDA:Germany TKD:Germany TKD:Germany TKD:Germany TKD:Austria

Address

1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, JPN, 103-8668

Website

https://www.takeda.com

Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.6 trillion in fiscal 2024. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with over 50% derived from the US, 20% from Japan, 20% from Europe and Canada.

Takeda Pharmaceutical Co Headlines

No Headlines